Leeward Investments LLC MA Has $15.25 Million Stock Holdings in Cabot Corporation $CBT

Leeward Investments LLC MA lifted its holdings in Cabot Corporation (NYSE:CBT) by 15.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 230,092 shares of the specialty chemicals company’s stock after buying an additional 30,976 shares during the period. Leeward Investments LLC MA owned about 0.43% of Cabot worth $15,250,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Allworth Financial LP boosted its position in shares of Cabot by 22.4% in the fourth quarter. Allworth Financial LP now owns 1,455 shares of the specialty chemicals company’s stock worth $96,000 after buying an additional 266 shares during the period. West Tower Group LLC acquired a new stake in Cabot during the fourth quarter valued at $745,000. Swiss Life Asset Management Ltd acquired a new stake in Cabot during the fourth quarter valued at $350,000. Denali Advisors LLC acquired a new stake in Cabot during the fourth quarter valued at $5,531,000. Finally, Connable Office Inc. boosted its position in Cabot by 5.1% during the fourth quarter. Connable Office Inc. now owns 9,505 shares of the specialty chemicals company’s stock valued at $630,000 after purchasing an additional 460 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Price Performance

NYSE CBT opened at $81.96 on Friday. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $86.43. The stock’s 50-day moving average is $74.76 and its two-hundred day moving average is $70.89. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The firm has a market cap of $4.23 billion, a P/E ratio of 15.49, a price-to-earnings-growth ratio of 10.84 and a beta of 0.78.

Cabot (NYSE:CBT) last posted its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. During the same period last year, the company earned $1.90 earnings per share. The business’s revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, analysts anticipate that Cabot Corporation will post 6.32 earnings per share for the current fiscal year.

Cabot Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.3%. This is an increase from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. Cabot’s dividend payout ratio is 34.03%.

Analyst Ratings Changes

A number of research firms recently issued reports on CBT. JPMorgan Chase & Co. lifted their price objective on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Jefferies Financial Group reissued a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday, February 4th. Finally, UBS Group lifted their price objective on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research report on Friday, May 8th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $80.25.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.